Literature DB >> 20138025

Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro.

Jayaraj Ravindran1, Gottumukkala V Subbaraju, Modukuri V Ramani, Bokyung Sung, Bharat B Aggarwal.   

Abstract

Curcumin, a component of turmeric (Curcuma longa), exhibits anti-inflammatory and anti-proliferative activities through the generation of reactive oxygen species (ROS). Curcumin (diferuloylmethane) contains two hydroxyl, two methoxy and two phenyl groups but how these groups contribute to its activity is poorly understood. We synthesized analogues that varied in inclusion of these groups and compared their activity. We found that bisdemethylcurcumin (BDC) was more potent than curcumin as an anti-inflammatory agent as indicated by suppression of TNF-induced NF-kappaB activation, more potent as an anti-proliferative agent, and more potent in inducing ROS. Hispolon, which lacks one aromatic unit in relation to curcumin, also exhibited enhanced anti-inflammatory and anti-proliferative activities. When synthetic curcumin (Cur-S) was compared with bisdemethylcurcumin (BDC), hispolon, hispolon methyl ether (HME), dehydroxy hispolon (DH), hydroxy hispolon (HH), methoxy hispolon methyl ether (MHME), and methoxy hispolon (MH), we found that following order of anti-inflammatory activity: BDC=Hispolon>HME>HH>Cur-S>MHME>MH>DH; for anti-proliferative: Hispolon>BDC>MHME>Cur-S>MH>HME=HH>DH; and for prooxidant: BDC>Cur-S=MHME>HH>MH+HME>DH (254-1414 mean fluorescence intensity). Thus, dehydroxy hispolon was least potent for all three activities. Overall the results indicate that the substitution of a hydroxyl group for a methoxy group at the meta positions of the phenyl rings in curcumin significantly enhanced the anti-inflammatory activity, and the removal of phenyl ring at the 7(th) position of the heptadiene back bone and addition of hydroxyl group significantly increased the anti-proliferative activity of curcumin. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138025      PMCID: PMC2846970          DOI: 10.1016/j.bcp.2010.01.033

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

1.  Assay for redox-sensitive transcription factor.

Authors:  M M Chaturvedi; A Mukhopadhyay; B B Aggarwal
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Anticancer potential of curcumin: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anushree Kumar; Alok C Bharti
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

3.  Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.

Authors:  Abdelhamid Liacini; Judith Sylvester; Wen Qing Li; Muhammad Zafarullah
Journal:  Matrix Biol       Date:  2002-04       Impact factor: 11.583

4.  Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.

Authors:  Yasunari Takada; Asok Mukhopadhyay; Gopal C Kundu; Ganapati H Mahabeleshwar; Sujay Singh; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2003-04-23       Impact factor: 5.157

Review 5.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 6.  Nuclear factor-kappaB: the enemy within.

Authors:  Bharat B Aggarwal
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

7.  Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].

Authors:  S Singh; B B Aggarwal
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

8.  Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.

Authors:  Alok C Bharti; Nicholas Donato; Bharat B Aggarwal
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

9.  Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.

Authors:  M T Huang; T Lysz; T Ferraro; T F Abidi; J D Laskin; A H Conney
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

Review 10.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.

Authors:  Bharat B Aggarwal; Bokyung Sung
Journal:  Trends Pharmacol Sci       Date:  2008-12-26       Impact factor: 14.819

View more
  17 in total

1.  Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs.

Authors:  Neduri V Balaji; Modukuri V Ramani; Arabela G Viana; Leticia P Sanglard; Jason White; Vanisree Mulabagal; Crystal Lee; Theophilus J Gana; Nosa O Egiebor; Gottumukkala V Subbaraju; Amit K Tiwari
Journal:  Bioorg Med Chem       Date:  2015-03-21       Impact factor: 3.641

Review 2.  Manganese superoxide dismutase in cancer prevention.

Authors:  Delira Robbins; Yunfeng Zhao
Journal:  Antioxid Redox Signal       Date:  2013-07-18       Impact factor: 8.401

3.  Role of Curcuminoids and Tricalcium Phosphate Ceramic in Rat Spinal Fusion.

Authors:  Daniel A Ryan; Jiongjia Cheng; Koichi Masuda; John R Cashman
Journal:  Tissue Eng Part C Methods       Date:  2020-11-13       Impact factor: 3.056

4.  Bright Side of Lignin Depolymerization: Toward New Platform Chemicals.

Authors:  Zhuohua Sun; Bálint Fridrich; Alessandra de Santi; Saravanakumar Elangovan; Katalin Barta
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

Review 5.  Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

Authors:  Alok Vyas; Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul Sarkar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Authors:  Stacey L Fossey; Misty D Bear; Jiayuh Lin; Chenglong Li; Eric B Schwartz; Pui-Kai Li; James R Fuchs; Joelle Fenger; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2011-03-28       Impact factor: 4.430

7.  HPLC method for simultaneous quantitative detection of quercetin and curcuminoids in traditional chinese medicines.

Authors:  Lee Fung Ang; Mun Fei Yam; Yvonne Tan Tze Fung; Peh Kok Kiang; Yusrida Darwin
Journal:  J Pharmacopuncture       Date:  2014-12

Review 8.  Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.

Authors:  Mareike Kelkel; Claus Jacob; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2010-10-12       Impact factor: 4.411

9.  Characterization of Curcumin/Cyclodextrin Polymer Inclusion Complex and Investigation on Its Antioxidant and Antiproliferative Activities.

Authors:  Jianping Chen; Xiaoming Qin; Saiyi Zhong; Suhua Chen; Weiming Su; Ying Liu
Journal:  Molecules       Date:  2018-05-15       Impact factor: 4.411

10.  The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2-STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells.

Authors:  Ying Wang; Pengjun Zhou; Shurong Qin; Dandan Xu; Yukun Liu; Wuyu Fu; Bibo Ruan; Li Zhang; Yi Zhang; Xiao Wang; Yuwei Pan; Sheng Wang; Haizhao Yan; Jinhong Qin; Xiaoyan Wang; Qiuying Liu; Zhiyun Du; Zhong Liu; Yifei Wang
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.